[
    [
        {
            "time": "2019-08-01",
            "original_text": "医药生物行业2019年8月月报:聚焦半年报业绩与新版医保目录发布情况",
            "features": {
                "keywords": [
                    "医药生物",
                    "半年报业绩",
                    "新版医保目录",
                    "发布情况"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业2019年8月月报:聚焦半年报业绩与新版医保目录发布情况",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 2
            }
        }
    ]
]